Company Description

MuReva Phototherapy is a new photobiomodulation therapy to prevent and treat radiation and chemotherapy-induced mucositis.

MuReva has developed a technology that harnesses Photobiomodulation to overcome the barriers which have limited the widespread adoption of medical lasers for the treatment of oral mucositis. Our technology delivers a safe, low-level visible light at a wavelength of 660nm and is designed to deliver Photobiomodulation therapy to the mouth of an individual undergoing localized radiation therapy in order to reduce the severity of oral mucositis.

Industry Sector
Biomedical & Health Tech


JumpStart Investment
Evergreen Fund